Provided by Tiger Fintech (Singapore) Pte. Ltd.

APRINOIA Therapeutics Inc.

Volume:- -
Turnover:- -
Market Cap:- -
PE:- -
High:- -
Open:- -
Low:- -
Close:0.2201
Loading ...
Oct 03, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 01, 2024

Correspondence

Form CORRESP - Correspondence
Oct 01, 2024

Correspondence

Form CORRESP - Correspondence
Sep 12, 2024

Correspondence

Form CORRESP - Correspondence
Sep 11, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Aug 28, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
May 17, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Mar 20, 2024

Correspondence

Form CORRESP - Correspondence
Mar 01, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 27, 2024

Correspondence

Form CORRESP - Correspondence
Feb 26, 2024

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jan 26, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Jan 26, 2024

Correspondence

Form CORRESP - Correspondence
Jan 30, 2019

Major Issues Report

[Amend] Current report, item 9.01
Jan 16, 2019

Business Combinations

Prospectuses and communications, business combinations
Jan 04, 2019

Business Combinations

Prospectuses and communications, business combinations
Dec 26, 2018

Business Combinations

Prospectuses and communications, business combinations
Dec 17, 2018

Business Combinations

Prospectuses and communications, business combinations
Dec 17, 2018

Business Combinations

Prospectuses and communications, business combinations
Dec 17, 2018

Business Combinations

Prospectuses and communications, business combinations